Phase 0 Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
Summary
The purpose of this study is to evaluate stereotactic radiosurgery (CyberKnife) plus chemotherapy for the treatment of potentially resectable adenocarcinoma of the pancreas.
General Information
NCT#: NCT02707315
Study ID: 12-169
Trial Phase: Phase 0
Trial Sponsor: The Cooper Health System
Therapies Used in This Trial: Gemcitabine, CyberKnife® Stereotactic Radiosurgery